In a detailed analysis of the Chinese situation, he deplores the gap between MOST-supported R&D and the regulations issued by the Ministry of Health, and expresses expectations that his situation will change in the upcoming new 5 years plan.
China Bio news release, March 18, 2015
David HU, Beike Biotechnology: China lags behind in stem-cell market development